LIQUID PHARMACEUTICAL COMPOSITION COMPRISING ENSIFENTRINE AND GLYCOPYRROLATE

The present invention relates to a liquid pharmaceutical composition suitable for administration by inhalation comprising: (i) ensifentrine particles; (ii) glycopyrrolate; and (iii) a diluent, which diluent comprises water, wherein: the glycopyrrolate is dissolved in the diluent; the concentration o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FRENCH Edward James, SPARGO Peter Lionel, HAYWOOD Phillip Andrew
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to a liquid pharmaceutical composition suitable for administration by inhalation comprising: (i) ensifentrine particles; (ii) glycopyrrolate; and (iii) a diluent, which diluent comprises water, wherein: the glycopyrrolate is dissolved in the diluent; the concentration of glycopyrrolate is less than or equal to 5.0 mg/mL; and the pH of the liquid pharmaceutical composition is from 3.0 to 6.0. The invention also relates to a nebuliser comprising the liquid pharmaceutical composition. La presente invención se refiere a una composición farmacéutica líquida adecuada para administración por inhalación que comprende: (i) partículas de ensifentrina; (ii) glicopirrolato; y (iii) un diluyente, cuyo diluyente comprende agua, en donde: el glicopirrolato se disuelve en el diluyente; la concentración de glicopirrolato es inferior o igual a 5.0 mg/mL; y el pH de la composición farmacéutica líquida es de 3.0 a 6.0. La invención también se refiere a un nebulizador que comprende la composición farmacéutica líquida.